FDA Inspection 870378 — Spectrum Pharmaceuticals, Inc.
The FDA completed an inspection of Spectrum Pharmaceuticals, Inc. on March 18, 2014 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Sponsor, Contract Research Organization